Medline MDLN
NASDAQ MDLN
$35.61 +0.67 (+1.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Medline (MDLN) Return on Capital Employed [ROCE] (2026)

Updated

Medline (MDLN) reported Return on Capital Employed [ROCE] of 5.57% for Q2 2026.

Analysis

Medline (MDLN) Return on Capital Employed [ROCE] (2026) Analysis & Trends

For FY2025, Medline posted Return on Capital Employed [ROCE] of 6.37%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn 8.30%
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn 7.98%
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn 6.42%
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn 18.58%
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn 8.34%
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn 13.69%
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn 10.83%
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn 11.99%
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn 6.00%
10 Medline 45.94 Bn 46.39 Bn 2.22 Bn 5.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 5.57%
API Access

Medline Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MDLN&period=max&api_key=YOUR_API_KEY